Burkholderia-associated polymyositis

BMJ Case Rep. 2024 Jan 16;17(1):e255782. doi: 10.1136/bcr-2023-255782.

Abstract

A diagnosis of polymyositis can readily be made when there is a typical history of proximal muscle weakness together with clinical findings, and there is corroboratory evidence in the form of elevated creatine kinase lactate dehydrogenase, aldolase, and serum glutamic-oxaloacetic transaminase (aspartate aminotransferase). A muscle biopsy usually helps in making the confirmatory diagnosis. A female in her 50s presented with non-healing multiple deep necrotic ulcers with muscle weakness. The initial possibility of vasculitis ulcers remained. Later, this proved to be a case of polymyositis with mildly elevated creatine kinase (which is usually not the case), atypical skin manifestations (usually there is no skin involvement), and negative extended myositis specific antibody panel with the growth of Burkholderia cepacia (perhaps the triggering factor). Hence, polymyositis can present with a myriad of atypical findings. Thus, thorough clinical examination and an integrated approach are necessary for early identification and treatment of the disease.

Keywords: Connective tissue disease; Musculoskeletal syndromes; Rheumatology.

Publication types

  • Case Reports

MeSH terms

  • Burkholderia*
  • Creatine Kinase
  • Female
  • Humans
  • Muscle Weakness
  • Polymyositis* / diagnosis
  • Polymyositis* / drug therapy
  • Ulcer

Substances

  • Creatine Kinase